Clinical trial
Surveillance With PET/CT and Liquid Biopsies of Stage I-III Lung Cancer Patients After Completion of Definitive Therapy; a Randomized Controlled Trial
NCT03740126 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Surveillance With PET/CT and Liquid Biopsies of Stage I-III Lung Cancer Patients After Completion of Definitive Therapy; a Randomized Controlled Trial
- Lead sponsor
- Rigshospitalet, Denmark
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 25, 2018
- Completion date
- August 1, 2026
- Enrollment
- 750 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.